Prostate cancer intensity-modulated radiotherapy and long term genitourinary toxicity: an evolving therapeutic landscape
Prostate Cancer Prostatic Dis
.
2023 Mar;26(1):1-2.
doi: 10.1038/s41391-022-00535-4.
Epub 2022 Apr 29.
Authors
Vérane Achard
1
,
Thomas Zilli
2
Affiliations
1
Department of Radiation Oncology, Geneva University Hospital, Geneva, and Faculty of Medicine, Geneva, Switzerland.
2
Department of Radiation Oncology, Geneva University Hospital, Geneva, and Faculty of Medicine, Geneva, Switzerland. Thomas.Zilli@hcuge.ch.
PMID:
35488121
DOI:
10.1038/s41391-022-00535-4
No abstract available
Publication types
Editorial
MeSH terms
Dose Fractionation, Radiation
Humans
Male
Prostatic Neoplasms* / drug therapy
Prostatic Neoplasms* / radiotherapy
Radiotherapy Dosage
Radiotherapy, Intensity-Modulated* / adverse effects
Treatment Outcome